Search

Search Results

• Study of risk factors and clinical management of patients with clinical non-response due to low plasma levels of anti-tubercular drugs

  Rupak Singla, Amitesh Gupta, Vikas Kumar, Chandrasekaran Padmapriyadarsini, Devika Tayal, Shweta Anand, Abhishek Faye, AK Hemanth Kumar, Madhumita Paul Choudhary

  2024-07-23

  https://doi.org/10.4081/monaldi.2024.3036

  1259

  PDF: 210

• Prescription patterns and drug utilization in respiratory tract infections: implications for antimicrobial stewardship at a tertiary care teaching hospital

  Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Chandrashekhar Mallikarjun Patil, Vinod Ashok Koujalagi, Sanatkumar Bharamu Nyamagoud

  2024-12-23

  https://doi.org/10.4081/monaldi.2024.3196

  1325

  PDF: 66

  SUPPLEMENTARY MATERIAL: 11

• Demographics and microbiological profile of Pneumonia in United Arab Emirates

  S. Al-Muhairi, T. Zoubeidi, M. Ellis, M. Gary Nicholls, W. Safa, J. Joseph

  2016-02-15

  https://doi.org/10.4081/monaldi.2006.580

  1777

  PDF: 840
• 

  Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study

  Saulius Diktanas, Oleksandr Korotych, Yuliia Sereda, Ogtay Gozalov, Olga Rubcova, Jay Achar

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1675

  1540

  PDF: 821

• Prolonged hospitalisation for immigrants and high risk patients with positive smear pulmonary tuberculosis

  R. Luzzati, M. Confalonieri, A. Cazzadori, P. Della Loggia, R. Cifaldi, C. Fabris, M. Biolo, M. Borelli, C. Longo, E. Concia

  2015-12-10

  https://doi.org/10.4081/monaldi.2011.229

  1074

  PDF: 674
• 

  Respiratory pathogens in patients with acute exacerbation of non-cystic fibrosis bronchiectasis from a developing country

  Shayan Shahid, Kausar Jabeen, Nousheen Iqbal, Joveria Farooqi, Muhammad Irfan

  2021-04-22

  https://doi.org/10.4081/monaldi.2021.1771

  1819

  PDF: 967
• 

  Determinants, risk factors and spatial analysis of multi-drug resistant pulmonary tuberculosis in Jodhpur, India

  Nikhilesh Ladha, Pankaj Bhardwaj, Nishant Kumar Chauhan, Kikkeri Hanumantha Setty Naveen, Vijaya Lakshmi Nag, Dandabathula Giribabu

  2022-01-18

  https://doi.org/10.4081/monaldi.2022.2026

  2970

  PDF: 1846
• 

  Factors associated with unfavourable treatment outcomes in people with HIV-associated tuberculosis in Armenia, 2015 to 2019

  Lilit Gevorgyan, Ruzanna Grigoryan, Kostyantyn Dumchev, Kristina Akopyan, Anush Khachatryan, Eduard Kabasakalyan, Trdat Grigoryan, Marina Safaryan, Vardan Avagyan, Sayohat Hasanova, Alberto Matteelli

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1648

  1666

  PDF: 803
• 

  Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19

  Varvara Solodovnikova, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Vera Auchynka, Dzmitry Katovich, Dzmitry Klimuk, Aliaksandr Skrahin, Svetlana Setkina, Iryna Charnysh, Askar Yedilbayev, Alena Skrahina

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1646

  3109

  PDF: 1449

  Supplementary: 269
• 

  Comparison of efficacy of bedaquiline and moxifloxacin in drug resistant pulmonary tuberculosis. A prospective observational study

  Govind Desai, Gopal Purohit, Hemant Borana, Kunal Deokar, Suresh Yogi

  2022-05-04

  https://doi.org/10.4081/monaldi.2022.2231

  2092

  PDF: 471

• Time to sputum culture conversion as a predictor of cure in multidrug-resistant tuberculosis patients: a multicenter retrospective cohort study in Pakistan

  Abdul Wahid, Nafees Ahmad, Fahad Saleem, Amjad Khan, Asad Khan, Faiz Ullah Khan, Farman Ullah Khan

  2025-04-24

  https://doi.org/10.4081/monaldi.2025.3200

  1154

  PDF_EARLY VIEW: 309

• Role of GeneXpert in the diagnosis of extrapulmonary tuberculosis

  Unnati Desai, Saby AK, Ketaki Utpat, Jyoti Bacche

  2024-07-25

  https://doi.org/10.4081/monaldi.2024.2909

  1193

  PDF: 174

• Nafithromycin: advancements in antibiotic therapy against community-acquired pneumonia-resistant pathogens

  Akshata Gore, Agadi Hiremath Viswanatha Swamy, Sanatkumar Bharamu Nyamagoud

  2025-08-05

  https://doi.org/10.4081/monaldi.2025.3340

  1924

  PDF_EARLY VIEW: 561

• Multidrug-resistant tuberculosis in Iran: a multicenter study

  Fatemeh Khelghati, Fatemeh Nasirpour Seilakhori, Mehdi Goudarzi, Shima Malekloo, Amir Hashem Shahidi Bonjar, Hossein Goudarzi, Mohammad Javad Nasiri

  2024-01-12

  https://doi.org/10.4081/monaldi.2024.2844

  1320

  PDF: 369

• Pharmacist-led education intervention to improve pulmonary tuberculosis treatment adherence through the Health Belief Model in Malaysia: a study protocol for a randomized controlled trial

  Rabbiya Ahmad, Siti Maisharah Sheikh Ghadzi, Irfhan Ali Bin Hyder Ali, Syed Azhar Syed Sulaiman, Amer Hayat Khan

  2025-06-26

  https://doi.org/10.4081/monaldi.2025.3474

  840

  PDF_EARLY VIEW: 383

• Impact of patient counseling on medication adherence and drug resistance patterns in tuberculosis patients

  Sanatkumar Bharamu Nyamagoud, Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Kadambari Solankure, Agadi Hiremath Viswanatha Swamy

  2025-06-19

  https://doi.org/10.4081/monaldi.2025.3434

  767

  PDF_EARLY VIEW: 271
• 

  Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018

  Mariana Buziashvili, Hayk Davtyan, Yuliia Sereda, Olga Denisiuk, Ogtay Gozalov, Nino Lomtadze, Arax Hovhannesyan

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1649

  2097

  PDF: 999

  Supplementary: 208